Key Market Indicators
**Iran Achieves Full Vaccination Coverage for One-Year-Olds in 2023** **Tehran, Iran** - Iran has achieved a significant milestone in its public health efforts, with vaccination coverage for children aged one year old reaching 100% in 2023. This marks a 1 percentage point increase from the 99% coverage recorded in 2022. The country has seen a consistent annual growth in vaccination rates, averaging a 0.2 percentage point increase each year since 1985. **Decline in Vaccine Imports Projected** Despite the impressive vaccination coverage, Iran's vaccine import market is projected to experience a decline. The value of vaccine imports is expected to decrease to approximately $26.6 million by 2028, down from around $30.3 million in 2023. This represents an average annual decline of 2.2%. Since 2002, Iran's demand for imported vaccines has been on a downward trend, falling by an average of 2.6% each year. This decrease could be attributed to various factors, including increased domestic production capabilities and changes in international trade dynamics. **Public Health and Economic Implications** The rise in vaccination coverage is a positive indicator of Iran's commitment to public health. However, the declining trend in vaccine imports could have broader implications for the country's healthcare infrastructure and its ability to respond to future public health challenges. The Iranian government and healthcare stakeholders will need to navigate these trends carefully to maintain high vaccination rates while addressing the economic aspects of vaccine procurement and production. **Looking Ahead** As Iran continues to improve its vaccination programs, the focus will likely shift towards sustaining these achievements and addressing the challenges posed by fluctuating vaccine import needs. The country's ability to balance domestic production with import requirements will be crucial in ensuring long-term public health stability.
